Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifeprunox in maintenance phase of schizophrenia
NCT00658645Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Mar 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of bifeprunox in schizophrenia, sponsored by Lundbeck. Started Mar 2008; status: terminated.
02
Drugs
bifeprunox
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00658645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00658645.